Investor's Business Daily on MSN
AT&T, IBD stock of the day, near buy point after surging on earnings
AT&T touts "covergence" while investors rotate into high-dividend stocks.
Investor's Business Daily on MSN
Biggest IPO in years is a winner so far, but this key test looms
Medline, the nation's largest provider of medical supplies, will release its first post-IPO earnings report on Wednesday.
Bitcoin tumbled to around $65,000 on Thursday amid a wave of liquidations driven by heavily bearish sentiment, but one technical indicator suggests the cryptocurrency could be set for not just a ...
Savvy traders use a bunch of tools to analyze markets. The relative strength index (RSI) is one of the most popular ones, sniffing out trend strength and momentum extremes. Right now, the RSI is ...
Billions of dollars in U.S. biosimilar erosion to AbbVie’s blockbuster immunology drug Humira is no match for its rising superstar Skyrizi. Despite the fall of what was once the world’s top-selling ...
Abstract: This study suggests a lightweight algorithm to estimate relative grip strength using forearm muscle deformation measured by infrared optical sensors. Unlike conventional approaches relying ...
Ms. Willis Aronowitz is a writer, a critic and the editorial director of The Meteor. In the middle of the night a few days before Thanksgiving, I woke up with excruciating abdominal cramps. A CT scan ...
Proactive therapeutic drug monitoring during adalimumab maintenance therapy is associated with substantially lower treatment failure and immunogenicity than reactive, symptom-driven monitoring in IBD.
Building strength and muscle comes with huge payoffs for health and longevity, but most Americans still don't lift weights or regularly practice any muscle-strengthening activity. Why? People often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results